Adjusting win statistics for dependent censoring

被引:24
作者
Dong, Gaohong [1 ]
Huang, Bo [2 ]
Wang, Duolao [3 ]
Verbeeck, Johan [4 ]
Wang, Jiuzhou [5 ]
Hoaglin, David C. [6 ]
机构
[1] iStats Inc, Long Isl City, NY 11101 USA
[2] Pfizer Inc, Groton, CT 06340 USA
[3] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England
[4] Univ Hasselt, I Biostat, DSI, Hasselt, Belgium
[5] ImmunoGen Inc, Waltham, MA USA
[6] Univ Massachusetts, Dept Populat & Quantitat Hlth Sci, Med Sch, Worcester, MA 01605 USA
关键词
Informative censoring; IPCW; net benefit; win odds; win ratio; GENERALIZED PAIRWISE COMPARISONS; PRIORITIZED OUTCOMES; INVERSE PROBABILITY; CLINICAL-TRIALS; RATIO; MORTALITY; MORBIDITY;
D O I
10.1002/pst.2086
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For composite outcomes whose components can be prioritized on clinical importance, the win ratio, the net benefit and the win odds apply that order in comparing patients pairwise to produce wins and subsequently win proportions. Because these three statistics are derived using the same win proportions and they test the same hypothesis of equal win probabilities in the two treatment groups, we refer to them as win statistics. These methods, particularly the win ratio and the net benefit, have received increasing attention in methodological research and in design and analysis of clinical trials. For time-to-event outcomes, however, censoring may introduce bias. Previous work has shown that inverse-probability-of-censoring weighting (IPCW) can correct the win ratio for bias from independent censoring. The present article uses the IPCW approach to adjust win statistics for dependent censoring that can be predicted by baseline covariates and/or time-dependent covariates (producing the CovIPCW-adjusted win statistics). Theoretically and with examples and simulations, we show that the CovIPCW-adjusted win statistics are unbiased estimators of treatment effect in the presence of dependent censoring.
引用
收藏
页码:440 / 450
页数:11
相关论文
共 35 条
[1]   Large sample inference for a win ratio analysis of a composite outcome based on prioritized components [J].
Bebu, Ionut ;
Lachin, John M. .
BIOSTATISTICS, 2016, 17 (01) :178-187
[2]  
Brunner E, 2020, SUCCESS ODDS MODIFIE
[3]   Generalized pairwise comparisons of prioritized outcomes in the two-sample problem [J].
Buyse, Marc .
STATISTICS IN MEDICINE, 2010, 29 (30) :3245-3257
[4]  
Dong G., 2020, STAT BIOPHARM RES, V12, P99, DOI DOI 10.1080/19466315.2019.1575279
[5]   The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring [J].
Dong, Gaohong ;
Mao, Lu ;
Huang, Bo ;
Gamalo-Siebers, Margaret ;
Wang, Jiuzhou ;
Yu, GuangLei ;
Hoaglin, David C. .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (05) :882-899
[6]   The win ratio: Impact of censoring and follow-up time and use with nonproportional hazards [J].
Dong, Gaohong ;
Huang, Bo ;
Chang, Yu-Wei ;
Seifu, Yodit ;
Song, James ;
Hoaglin, David C. .
PHARMACEUTICAL STATISTICS, 2020, 19 (03) :168-177
[7]   The stratified win ratio [J].
Dong, Gaohong ;
Qiu, Junshan ;
Wang, Duolao ;
Vandemeulebroecke, Marc .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (04) :778-796
[8]   A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components [J].
Dong, Gaohong ;
Li, Di ;
Ballerstedt, Steffen ;
Vandemeulebroecke, Marc .
PHARMACEUTICAL STATISTICS, 2016, 15 (05) :430-437
[9]  
Efron B, 1967, P 5 BERKELEY S MATH, P831
[10]   Graphing the Win Ratio and its components over time [J].
Finkelstein, Dianne M. ;
Schoenfeld, David A. .
STATISTICS IN MEDICINE, 2019, 38 (01) :53-61